Precancerous cervical lesions associated with human papillomavirus declined sharply in women aged 18–24 between 2008 and 2016, likely reflecting increasing HPV vaccination and changes in detection of these lesions due to updated cervical cancer screening and management recommendations, the Centers for Disease Control and Prevention reported today. Screen-detected, high-grade cervical lesions develop within a few years after infection and have been used to monitor HPV vaccine impact because HPV-associated cancers typically take decades to develop. In 2006, HPV vaccine was licensed and recommended for girls aged 11-12 and for catch-up vaccination through age 26.

Related News Articles

Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services Aug. 21 announced the creation of a Healthcare Advisory…
Headline
A KFF analysis published Aug. 20 provides a state-by-state allocation of Congressional Budget Office estimates that 10 million people could be uninsured by…
Headline
The Centers for Medicare & Medicaid Services today announced a nationwide initiative aimed at reinforcing eligibility standards for Medicaid and the…
Headline
The Centers for Medicare & Medicaid Services has issued the 2025-2026 Medicaid Managed Care Rate Development Guide for states to use when setting managed…
Headline
The U.S. Departments of Labor, Health and Human Services, and the Treasury announced Aug. 7 that they are reconsidering the definition of short-term, limited-…
Headline
A new analysis published Aug. 6 by the Peterson Center on Healthcare and KFF found that Health Insurance Marketplace insurers will propose a median premium…